![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Moderna, Inc. Common Stock (MRNA) - Nasdaq
Feb 1, 2025 · Discover real-time Moderna, Inc. Common Stock (MRNA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead …
Moderna, Inc. Common Stock (MRNA) Real-Time Quotes - Nasdaq
Aug 30, 2024 · Get real-time updates on Moderna, Inc. Common Stock (MRNA) stock quotes, trades, and more. Make informed investments with Nasdaq.
Is Moderna a Bad-News Buy for 2025? - Nasdaq
Jan 16, 2025 · Moderna may reach its product approval and launch goals -- but this will take a few years. Meanwhile, the market could continue to sanction the biotech if sales remain lackluster …
Moderna, Inc. Common Stock (MRNA) Historical Data | Nasdaq
Find the latest historical data for Moderna, Inc. Common Stock (MRNA) at Nasdaq.com. View historical data in a monthly, bi-annual, or yearly format.
Moderna Unusual Options Activity For January 22 - Nasdaq
Jan 22, 2025 · Today, Benzinga's options scanner spotted 13 options trades for Moderna. This isn't normal. The overall sentiment of these big-money traders is split between 46% bullish and …
Moderna, Inc. Common Stock (MRNA) Pre-Market - Nasdaq
Get the latest updates on Moderna, Inc. Common Stock (MRNA) pre market trades, share volumes, and more. Make informed investments with Nasdaq.
Moderna Options Trading: A Deep Dive into Market Sentiment
Feb 3, 2025 · Looking at options history for Moderna (NASDAQ:MRNA) we detected 26 trades. If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened …
Moderna Stock: A Deep Dive Into Analyst Perspectives (10 …
Jan 15, 2025 · Ratings for Moderna (NASDAQ:MRNA) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Is Moderna Stock a No-Brainer Buy on the Sell-Off? - Nasdaq
Jan 15, 2025 · If we assume Moderna only hits the low end of its 2025 revenue forecast, the stock trades at roughly 9 times forward sales. That's well above the 7.2 price-to-sales ratio for the …
Is Moderna Stock a Buy? - Nasdaq
Jan 19, 2025 · Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index.